Neisseria gonorrhoeae infection: Clinical sciences

1,783views

Neisseria gonorrhoeae infection: Clinical sciences

Reproductive and Breast

Reproductive and Breast

Approach to breast pain (mastalgia): Clinical sciences
Approach to nipple discharge: Clinical sciences
Breast abscess: Clinical sciences
Mastitis: Clinical sciences
Approach to a breast mass and asymmetry: Clinical sciences
Breast cancer screening: Clinical sciences
Breast cyst: Clinical sciences
Breast papilloma: Clinical sciences
Ductal carcinoma in situ: Clinical sciences
Fibroadenoma: Clinical sciences
Fibrocystic breast changes: Clinical sciences
Inflammatory breast cancer: Clinical sciences
Invasive ductal carcinoma: Clinical sciences
Invasive lobular carcinoma: Clinical sciences
Lobular carcinoma in situ: Clinical sciences
Emergency contraception: Clinical sciences
Infertility: Clinical sciences
Permanent contraception (sterilization): Clinical sciences
Reversible contraception: Clinical sciences
Approach to vaginal discharge: Clinical sciences
Approach to vulvar skin disorders: Clinical sciences
Bacterial vaginosis: Clinical sciences
Chlamydia trachomatis infection: Clinical sciences
Neisseria gonorrhoeae infection: Clinical sciences
Pelvic inflammatory disease: Clinical sciences
Sexually transmitted infection screening (Family medicine): Clinical sciences
Sexually transmitted infection screening (GYN): Clinical sciences
Uterine leiomyoma: Clinical sciences
Vaginal trichomoniasis: Clinical sciences
Vulvar skin disorders (benign): Clinical sciences
Vulvovaginal candidiasis: Clinical sciences
Approach to postmenopausal bleeding: Clinical sciences
Perimenopause, menopause, and primary ovarian insufficiency: Clinical sciences
Adenomyosis: Clinical sciences
Approach to abnormal uterine bleeding in reproductive-aged patients: Clinical sciences
Approach to chronic pelvic pain (GYN): Clinical sciences
Approach to dysmenorrhea: Clinical sciences
Approach to primary amenorrhea: Clinical sciences
Approach to secondary amenorrhea: Clinical sciences
Endometriosis: Clinical sciences
Polycystic ovary syndrome (PCOS): Clinical sciences
Premenstrual syndrome (PMS) and premenstrual dysphoric disorder (PMDD): Clinical sciences
Primary dysmenorrhea: Clinical sciences
Approach to adnexal masses: Clinical sciences
Cervical cancer screening: Clinical sciences
Cervical dysplasia and cervical cancer: Clinical sciences
Endometrial intraepithelial neoplasia (hyperplasia) and carcinoma: Clinical sciences
Gestational trophoblastic disease (GTD) and neoplasia (GTN): Clinical sciences
Ovarian cancer: Clinical sciences
Vulvar dysplasia and vulvar cancer: Clinical sciences
Adnexal torsion: Clinical sciences
Benign prostatic hypertrophy and prostate cancer: Clinical sciences
Testicular torsion (pediatrics): Clinical sciences
Testicular cancer: Clinical sciences
Anatomy clinical correlates: Breast
Anatomy clinical correlates: Female pelvis and perineum
Anatomy clinical correlates: Inguinal region
Anatomy clinical correlates: Male pelvis and perineum
Chlamydia trachomatis
Gardnerella vaginalis (Bacterial vaginosis)
Haemophilus ducreyi (Chancroid)
Neisseria gonorrhoeae
Staphylococcus aureus
Treponema pallidum (Syphilis)
Candida
Trichomonas vaginalis
Herpes simplex virus
Human papillomavirus
Benign breast conditions: Pathology review
Breast cancer: Pathology review
Amenorrhea: Pathology review
Cervical cancer: Pathology review
Ovarian cysts and tumors: Pathology review
Sexually transmitted infections: Vaginitis and cervicitis: Pathology review
Uterine disorders: Pathology review
Vaginal and vulvar disorders: Pathology review
Disorders of sex chromosomes: Pathology review
Disorders of sexual development and sex hormones: Pathology review
Sexually transmitted infections: Warts and ulcers: Pathology review
Penile conditions: Pathology review
Prostate disorders and cancer: Pathology review
Testicular and scrotal conditions: Pathology review
Testicular tumors: Pathology review
Androgens and antiandrogens
Aromatase inhibitors
Estrogens and antiestrogens
Progestins and antiprogestins
Uterine stimulants and relaxants
Adrenergic antagonists: Alpha blockers
PDE5 inhibitors

Decision-Making Tree

Transcript

Watch video only

Neisseria gonorrhoeae is the second most common sexually transmitted bacterial infection in the United States, and it’s a mandatory reportable infection as a public health measure. It can affect multiple anatomic sites, most commonly the urethra and cervix, but also the eyes, oropharynx, and rectum. Many infections are asymptomatic.

Now, untreated infections can result in pelvic inflammatory disease, which increases the patient’s risk for ectopic pregnancy, infertility, and chronic pelvic pain. Transmission of gonorrhea to the neonate can occur during vaginal delivery. Gonorrhea in neonates can lead to infections such as ophthalmia neonatorum, also called gonococcal conjunctivitis, which may lead to blindness.

Your first step in evaluating a patient who presents with a chief concern suggesting Neisseria gonorrhoeae infection is a focused history and physical exam.

Let’s begin with biologically male patients. First, obtain a complete sexual history including questions about new partners and both oral and anal intercourse. Be sure to discuss sexual activity, particularly recent sexual activity or new partners. Provide a private, confidential discussion. Although it may be difficult, you should ask caregivers of young patients to step out of the room for this discussion. Additionally, always consider sexual assault or abuse whenever a young patient has a positive sexual activity history, especially if the patient is a child. If there is abuse going on, you will need to follow up with allegations of abuse in accordance with your State’s law.

Now patients may report a variety of symptoms, corresponding to the site of infection. They may describe a sore, itchy throat and difficulty swallowing or pelvic symptoms such as pelvic pain, dysuria, thick greenish or yellow urethral discharge, or testicular pain or swelling. Lastly, they might report rectal symptoms including painful bowel movements or rectal spotting.

On a physical exam, your findings will reflect the site of infection. Signs of conjunctivitis include erythema of the conjunctiva, swelling of the eyelid, or purulent ocular discharge. With pharyngitis, you might find an erythematous throat and cervical lymphadenopathy. Urethritis may present with purulent urethral discharge. In the case of epididymitis, you might find unilateral swelling and tenderness of a testicle as well as abdominal tenderness. Next, prostatitis typically presents with a firm, tender, and edematous prostate on a digital rectal exam. Lastly, proctitis may present with swollen, tender, and erythematous rectal mucosa.

Here is a high-yield fact! Disseminated gonococcal infections are unusual but clinically significant. These patients may present with a rash on the hands and feet, arthralgias, tenosynovitis, or septic arthritis, and they may develop endocarditis and meningitis. Additionally, biological females may have pelvic inflammatory disease and perihepatitis. Treatment includes hospitalization, appropriate antibiotics, and consultation with an infectious disease specialist.

Now back to the patient. If you suspect Neisseria gonorrhoeae infection, your next step is to perform laboratory testing for gonorrhea. Your history and physical exam will guide your testing sites. A nucleic acid amplification test, or NAAT, can be performed by swabbing the appropriate site, which may include the eye, throat, urethra, or rectum. A first-void urine collection can also be sent for NAAT testing to diagnose urogenital infections. Alternatively, a gonorrhea culture can be performed by swabbing the site of the suspected infection. Although historically culture was used for diagnosis, culture is rarely performed today. Finally, a gram stain of urethral discharge can be obtained if the patient has signs of urethritis.

Time for another high-yield fact! In biologically male patients, a positive gram stain of urethral discharge is highly specific and sensitive for diagnosing symptomatic gonococcal urethritis. A positive stain will demonstrate polymorphonuclear leukocytes with intracellular gram-negative diplococci. This test is not useful for screening for gonococcal infections of the throat or rectum. Also, be aware that in asymptomatic patients, a negative gram stain does not rule out infection.

Alright, now that we ordered tests, let’s talk about the results. If NAAT or culture are negative, consider an alternative diagnosis. However, if the NAAT, culture, or gram stain is positive, you have made your diagnosis of Neisseria gonorrhoeae infection.

Treat patients with an antibiotic, such as intramuscular ceftriaxone. Also, keep in mind that chlamydia coinfection is quite common; so if chlamydia infection has not been excluded, you should treat for chlamydia as well by adding an oral antibiotic like doxycycline or azithromycin. To ensure compliance, treat patients on-site or refer to an STI clinic for same-day treatment. After administering antibiotics to your patient, be sure to refer all sexual partners for evaluation and treatment as well. If partners cannot access services for evaluation and treatment, consider expedited partner therapy, or EPT, which allows you to treat their sexual partners without requiring them to come in for an examination. In addition, counsel patients to abstain from intercourse until 7 days following completion of treatment, and until symptoms have resolved and all partners are treated.

Since patients with one STI are at high risk for another, perform additional STI testing to screen for chlamydia, syphilis, and HIV. You should offer HIV pre-exposure prophylaxis, or PrEP, to patients who are HIV-negative because it reduces the risk of acquiring HIV. Finally, in cases of pharyngitis, perform a test of cure in 7 to 14 days. If tests remain positive or symptoms persist, be sure to obtain cultures with sensitivities. Pharyngitis is harder to eradicate than urogenital or rectal gonorrhea and is a large source of community transmission. Retest all patients, regardless of infection site, at 12 weeks after treatment, as there is a high prevalence of gonorrhea among patients with previous infections.

Sources

  1. "Sexually Transmitted Infections Treatment Guidelines, 2021" MMWR. Recommendations and Reports (2021)
  2. "Preexposure prophylaxis for the prevention of HIV infection in the United States - 2021 update" Centers for Disease Control and Prevention (2021)
  3. "Expedited Partner Therapy" Obstetrics & Gynecology (2018)